DOI:10.1093/jjco/hyq243; Corpus ID: 16566108. Translation and validation of EORTC QLQ-C30 into Indonesian version for cancer patients in Indonesia.

2020-07-20 · Cost-effectiveness models require quality of life utilities calculated from generic preference-based questionnaires, such as EQ-5D. We evaluated the performance of available algorithms for QLQ-C30 conversion into EQ-5D-3L based utilities in a metastatic colorectal cancer (mCRC) patient population and subsequently developed a mCRC specific algorithm.

In the process of performing this validation, we aimed to also identify issues surrounding the approach to validation of mapping algorithms. Methods Identification and … QLQ-C30, a generic cancer instrument, has previously been validated numerous times for different cancer cohorts [19,20] in different countries and cultures [21][22][23] [24], as well as for Corpus ID: 26672545. Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients. @article{Demirci2011ValidationOT, title={Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients.}, author={S.

Qlq-c30 validation

2021-01-07 · Background In oncology practice, eliciting the patient’s perspective on their quality of life (QOL) adds important information and value to their treatment and care. The European Organization for Research and Treatment of Cancer QOL questionnaire (EORTC QLQ-C30) is the most commonly used tool for this purpose but has not been validated in Kenya. The present study aimed to conduct a 2018-11-12 · Background Given the high cure-rate for testicular cancer (TC) and the patients’ young age, comprehensive evaluation of health-related quality of life (HRQOL) is an important consideration in this patient population. The EORTC QLQ-TC26 questionnaire module has been developed to supplement the EORTC QLQ-C30 in assessing TC-specific HRQOL in clinical trials and routine clinical practice. This 2020-06-09 · The Chilean-Spanish version of the QLQ-C30 and some modules have been validated before [ 17, 18 ].

7 Aug 2019 The QLQ-C30 summary score was compared to the original QLQ-C30 scales using general (age, sex, Eastern Cooperative Oncology Group

The validation of the EORTC QLQ-C30 in-cluded testing of discrimination, internal consistency, sensitivity, and construct validity. Furthermore, external convergent validity was measured by assessing how SF-36 and EORTC Validation of the EORTC QLQ-C30 and QLQ-BR23 instruments One of the key objectives of the current study was to examine the concurrent validity of EORTC QLQ-C30 using EQ5D as the comparison instrument.

7 Aug 2019 The QLQ-C30 summary score was compared to the original QLQ-C30 scales using general (age, sex, Eastern Cooperative Oncology Group

The reliability of the EORTC QLQ-C30 subscales is modest, thus limiting their utility in both clinical and research settings. The Moroccan Arabic Dialectal version of the QLQ-C30 is a valid and reliable measure of health-related quality of life (HRQOL) in patients with colorectal cancer. These results support that the EORTC QLQ-C30 (version 3.0) has proven to be a reliable and valid measure of the quality of life in Thai patients with various types of cancer. Similar articles Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample. These results demonstrate that the Korean version of the EORTC QLQ-C30 is a valid instrument for evaluating Korean-speaking patients with cancer, and can be used to distinguish clearly between subgroups of patients of differing performance status. This is a preview of subscription content, log in to check access. Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement.

One hundred and seventy patients completed three questionnaires EORTC QLQ-C30, the Beck depression inventory (BDI), and a brief pain inventory (BPI). 1997-04-01 · Validation of the EORTC QLQ-C30 443 The questionnaire used for the gynecological cancer pa- tients contained 73 additional items, some of which were inserted among the items of the EORTC QLQ-C30. Only the results concerning the EORTC QLQ-C30 are reported here.
Ansökan om svenskt personnummer skatteverket

Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients. @article{Demirci2011ValidationOT, title={Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients.}, author={S. Demirci and E. Eser and Z. Ozsaran and Deniz Tankişi and A. Aras and Gul Ozaydemir and Y. Anacak}, journal={Asian Pacific Background The increasing incidence of colorectal cancer in Taiwan has generated a need for a disease-specific quality-of-life measuring instrument.

Methods: In a cross-sectional study, a heterogeneous sample of cancer patients (n = 57) self-administered a questionnaire containing the QLQ-C30, the Short Form 36 Health Survey (SF-36) and 2020-07-20 · Cost-effectiveness models require quality of life utilities calculated from generic preference-based questionnaires, such as EQ-5D. We evaluated the performance of available algorithms for QLQ-C30 conversion into EQ-5D-3L based utilities in a metastatic colorectal cancer (mCRC) patient population and subsequently developed a mCRC specific algorithm. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): Translation and validation study of the Iranian version Article Dec 1999 Health related quality of life (HRQOL) has increasingly emphasized on cancer patients.
Utbildning projektledare göteborg

QLQ-C30, a generic cancer instrument, has previously been validated numerous times for different cancer cohorts [19,20] in different countries and cultures [21][22][23] [24], as well as for

These results support that the EORTC QLQ-C30 (version 3.0) has proven to be a reliable and valid measure of the quality of life in Thai patients with various types of cancer. Similar articles Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample. These results demonstrate that the Korean version of the EORTC QLQ-C30 is a valid instrument for evaluating Korean-speaking patients with cancer, and can be used to distinguish clearly between subgroups of patients of differing performance status. This is a preview of subscription content, log in to check access.

Pension risk transfer

RESULTS: Correlations of the CAT and QLQ-C30 ranged from 0.81 to 0.93 across domains. The mean relative reduction in floor and ceiling effects using the CAT was 42% (range 3-99%). Analyses of known groups validity and responsiveness indicated that, across domains, mean sample size requirements for the CAT were 72% and 70%, respectively, of

In the process of performing this validation, we aimed to also identify issues surrounding RESULTS: Correlations of the CAT and QLQ-C30 ranged from 0.81 to 0.93 across domains. The mean relative reduction in floor and ceiling effects using the CAT was 42% (range 3-99%). Analyses of known groups validity and responsiveness indicated that, across domains, mean sample size requirements for the CAT were 72% and 70%, respectively, of The EORTC Quality of Life Study Group has developed a questionnaire for evaluating Quality of Life in international clinical trials: QLQ‐C30. The purpose of the present work is to validate the third version of this questionnaire (3.0) for use in Spain. Mapping algorithms can be used to generate health state utilities when a preference-based instrument is not included in a clinical study. Our aim was to investigate the external validity of published mapping algorithms in non-small cell lung cancer (NSCLC) between the EORTC QLQ-C30 and EQ-5D instruments and to propose methodology for validating any mapping algorithms.